A novel regulatory role of gp49B on dendritic cells in T-cell priming

European Journal of Immunology

Volumn 38, Issue 9, 2008, Pages 2426-2437

  Kasai, Satoshi ^a,b   Inui, Masanori ^a   Nakamura, Kyohei ^a   Kakizaki, Yuta ^a   Endo, Shota ^a   Nakamura, Akira ^a   Ito, Sadayoshi ^b   Takai, Toshiyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antigen presentation; Costimulation; DC; Regulatory receptor; Tolerance

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 2; PROTEIN GP49B; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; LILRB4 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPLEEN CELL; T LYMPHOCYTE; UPREGULATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CYTOKINES; DENDRITIC CELLS; GRAFT VS HOST DISEASE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS;

EID: 55249122303     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200737550     Document Type: Article

References (57)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Colonna, M., Trinchieri, G. and Liu, Y. J., Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004. 5: 1219-1226.
3. Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L. and Vivier, E., Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005. 106: 2252-2258.
4. Steinman, R. M. and Nussenzweig, M. C., Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 2002. 99: 351-358.
5. Barclay, A. N. and Brown,M. H., The SIRP family of receptors and immune regulation. Nat. Rev. Immunol. 2006. 6: 457-464.
6. Kalergis, A. M. and Ravetch, J. V., Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. 2002. 195: 1653-1659.
7. Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S. et al., Tolerization of dendritic cells by TS cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 2002. 3: 237-243.
8. -/- mice. Nat. Immunol. 2002. 3: 542-548.
9. + myeloid precursors. Eur. J. Immunol. 2000. 30: 827-833.
10. Suciu-Foca, N., Manavalan, J. S., Scotto, L., Kim-Schulze, S., Galluzzo, S., Naiyer, A. J., Fan, J. et al., Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: Review. Int. Immunopharmacol. 2005. 5: 7-11.
11. Borges, L. and Cosman, D., LIRs/ILTs/MIRs, inhibitory and stimulatory Ig- superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 2000. 11: 209-217.
12. Katz, H. R., Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells. Mol. Immunol. 2002. 38: 1301-1305.
13. Ravetch, J. V. and Lanier, L. L., Immune inhibitory receptors. Science 2000. 290: 84-89.
14. Takai, T., Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2002. 2: 580-592.
15. Tomasello, E., Olcese, L., Vely, F., Geourgeon, C., Blery, M., Moqrich, A., Gautheret, D. et al., Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J. Biol. Chem. 1998. 273: 34115-34119.
16. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C. and Phillips, J. H., Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998. 391: 703-707.
17. Fodor, S., Jakus, Z. and Mocsai, A., ITAM-based signaling beyond the adaptive immune response. Immunol. Lett. 2006. 104: 29-37.
18. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. and Amigorena, S., Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1999. 1: 362-368.
19. Akiyama, K., Ebihara, S., Yada, A., Matsumura, K., Aiba, S., Nukiwa, T. and Takai, T., Targeting apoptotic tumor cells to Fcγ R provides efficient and versatile vaccination against tumors by dendritic cells. J. Immunol. 2003. 170: 1641-1648.
20. Yada, A., Ebihara, S., Matsumura, K., Endo, S., Maeda, T., Nakamura, A., Akiyama, K. et al., Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake. Cell. Immunol. 2003. 225: 21-32.
21. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T. et al., Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 1999. 189: 371-380.
22. Clynes, R. A., Towers, T. L., Presta, L. G. and Ravetch, J. V., Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 2000. 6: 443-446.
23. -/- mice. Nat. Immunol. 2004. 5: 623-629.
24. Katz, H. R., LeBlanc, P. A. and Russell, S. W., Two classes of mouse mast cells delineated by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1983. 80: 5916-5918.
25. Zhou, J. S., Friend, D. S., Feldweg, A. M., Daheshia, M., Li, L., Austen, K. F. and Katz, H. R., Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: Evidence for an important role for gp49B1 expression on neutrophils. J. Exp. Med. 2003. 198: 1243-1251.
26. Daheshia, M., Friend, D. S., Grusby, M. J., Austen, K. F. and Katz, H. R., Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J. Exp. Med. 2001. 194: 227-234.
27. Kuroiwa, A., Yamashita, Y., Inui, M., Yuasa, T., Ono, M., Nagabukuro, A., Matsuda, Y. and Takai, T., Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. J. Biol. Chem. 1998. 273: 1070-1074.
28. Lee, K. H., Ono, M., Inui, M., Yuasa, T. and Takai, T., Stimulatory function of gp49A, a murine Ig-like receptor, in rat basophilic leukemia cells. J. Immunol. 2000. 165: 4970-4977.
29. Katz, H. R., Vivier, E., Castells, M. C., McCormick, M. J., Chambers, J. M. and Austen, K. F., Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc. Natl. Acad. Sci. USA 1996. 93: 10809-10814.
30. 3 interaction inhibits antigen-induced mast cell activation. Nat. Immunol. 2001. 2: 436-442.
31. Pytela, R., Pierschbacher, M. D., Ginsberg, M. H., Plow, E. F. and Ruoslahti, E., Platelet membrane glycoprotein IIb/IIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986. 231: 1559-1562.
32. Moulder, K., Roberts, K., Shevach, E. M. and Coligan, J. E., The mouse vitronectin receptor is a T cell activation antigen. J. Exp. Med. 1991. 173: 343-347.
33. Cheresh, D. A. and Harper, J. R., Arg-Gly-Asp recognition by a cell adhesion receptor requires its 130-kDa α subunit. J. Biol. Chem. 1987. 262: 1434-1437.
34. Matsumoto, Y., Wang, L. L., Yokoyama, W. M. and Aso, T., Uterine macrophages express the gp49B inhibitory receptor in midgestation. J. Immunol. 2001. 166: 781-786.
35. Wang, L. L., Chu, D. T., Dokun, A. O. and Yokoyama, W. M., Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 2000. 164: 5215-5220.
36. Gu, X., Laouar, A., Wan, J., Daheshia, M., Lieberman, J., Yokoyama, W. M., Katz, H. R. and Manjunath, N., The gp49B1 inhibitory receptor regulates the IFN-γ responses of T cells and NK cells. J. Immunol. 2003. 170: 4095-4101.
37. Rojo, S., Stebbins, C. C., Peterson, M. E., Dombrowicz, D., Wagtmann, N. and Long, E. O., Natural killer cells and mast cells from gp49B null mutant mice are functional. Mol. Cell Biol. 2000. 20: 7178-7182.
38. 3 integrin chains on murine lymphocytes. Proc. Natl. Acad. Sci. USA 1996. 93: 14698-14703.
39. Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D. and Suciu-Foca, N., High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 2003. 11: 245-258.
40. Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J. and Emerson, S. G., Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999. 285: 412-415.
41. Feldweg, A. M., Friend, D. S., Zhou, J. S., Kanaoka, Y., Daheshia, M., Li, L., Austen, K. F. and Katz, H. R., gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo. Eur. J. Immunol. 2003. 33: 2262-2268.
42. Ju, X. S., Hacker, C., Scherer, B., Redecke, V., Berger, T., Schuler, G., Wagner, H. et al., Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 2004. 331: 159-164.
43. Vlad, G., Piazza, F., Colovai, A., Cortesini, R., Della Pietra, F., Suciu-Foca, N. and Manavalan, J. S., Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum. Immunol. 2003. 64: 483-489.
44. Sturmhofel, K., Brando, C., Martinon, F., Shevach, E. M. and Coligan, J. E., Antigen-independent, integrin-mediated T cell activation. J. Immunol. 1995. 154: 2104-2111.
45. 3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J. Biol. Chem. 2003. 278: 26983-26991.
46. Caux, C., Vanbervliet, B., Massacrier, C., Azuma, M., Okumura, K., Lanier, L. L. and Banchereau, J., B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 1994. 180: 1841-1847.
47. Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H. et al., The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 1994. 180: 1849-1860.
48. Martin, A. M., Kulski, J. K., Witt, C., Pontarotti, P. and Christiansen, F. T., Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 2002. 23: 81-88.
49. Bryceson, Y. T., Torgersen, K. M., Inngjerdingen, M., Berg, S. F., Hoelsbrekken, S. E., Fossum, S. and Dissen, E., The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells. Eur. J. Immunol. 2005. 35: 1230-1239.
50. + T suppressor cells. J. Immunol. 2006. 176: 2790-2798.
51. + regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005. 106: 3490-3497.
52. Pulendran, B., Palucka, K. and Banchereau, J., Sensing pathogens and tuning immune responses. Science 2001. 293: 253-256.
53. Kapsenberg, M. L., Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003. 3: 984-993.
54. Iwasaki, A. and Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004. 5: 987-995.
55. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. et al., Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 competewith CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 2003. 100: 8856-8861.
56. Takai, T., Li, M., Sylvestre, D., Clynes, R. and Ravetch, J. V., FcR γ chain deletion results in pleiotrophic effector cell defects. Cell 1994. 76: 519-529.
57. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.